TVRD
Tvardi Therapeutics, Inc.
Key Financials
Operating Income
$-26748000
↑ 54.2%
Revenue
$7.1M
↓ 66.0%
Net Income
$-18214000
↑ 74.3%
Total Assets
$32.1M
↓ 26.8%
Total Liabilities
$11.1M
↓ 77.0%
EPS (Diluted)
$-3.26
↑ 79.0%
Shareholders' Equity
$20.9M
↑ 556.0%
Operating Cash Flow
$-23499000.00
↑ 61.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 4 | 6/11/2026 | View on SEC |
| 8-K | 6/11/2026 | View on SEC |
| EFFECT | 5/13/2026 | View on SEC |
| EFFECT | 5/12/2026 | View on SEC |
| POS AM | 5/8/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TVRD |
| Company Name | Tvardi Therapeutics, Inc. |
| CIK | 1346830 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (713) 489-8654 |